- Home
- EDUC vs QNRX Comparison
EDUC vs QNRX Comparison
Compare EDUC & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDUC | QNRX |
|---|---|---|
| Founded | 1965 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 10.7M |
| IPO Year | 1995 | 2023 |
Fundamental Metrics
Financial Performance| Metric | EDUC | QNRX |
|---|---|---|
| Price | $1.49 | $5.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 46.2K | 20.8K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $34,191,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $5.20 |
| 52 Week High | $1.84 | $41.80 |
Technical Indicators
Market Signals| Indicator | EDUC | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 75.21 | 43.31 |
| Support Level | $1.25 | $5.34 |
| Resistance Level | $1.54 | $6.98 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 79.17 | 47.65 |
Price Performance
Historical ComparisonAbout EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.